MaMaLoc: Magnetic Marker Localisation for non-palpable breast lesions. A Feasibility Study.
Completed
- Conditions
- breast cancerbreast carcinoma1000629110006295
- Registration Number
- NL-OMON42528
- Lead Sponsor
- ederlands Kanker Instituut
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 15
Inclusion Criteria
* Unifocal, non-palpable breast lesion
* Treated with breast sparing surgery
* Using radio-active seed localisation (RSL)
* Age > 18 years.
Exclusion Criteria
* Treated with neo-adjuvant chemotherapy
* Planned MRI in the period between marker placement and surgery
* Tumor depth >4cm
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Identification rate (IR) of the magnetic marker relative to the total amount of<br /><br>included subjects (percentage).</p><br>
- Secondary Outcome Measures
Name Time Method <p>Not applicable. </p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of magnetic marker localization in non-palpable breast lesions?
How does magnetic marker localization compare to wire localization in breast cancer surgery outcomes?
What biomarkers correlate with successful lesion localization using MaMaLoc technology?
Are there specific adverse events associated with magnetic marker localization for breast tumors?
What are the potential applications of magnetic marker localization in combination with other breast cancer therapies?